[HTML][HTML] Hepatocellular carcinoma recurrence and mortality rate post liver transplantation: meta-analysis and systematic review of real-world evidence
KI Bzeizi, M Abdullah, K Vidyasagar, SA Alqahthani… - Cancers, 2022 - mdpi.com
Simple Summary This is a systematic and meta-analysis study that looked at the
hepatocellular carcinoma recurrence rate and its risk factors after liver transplantation. The …
hepatocellular carcinoma recurrence rate and its risk factors after liver transplantation. The …
Systemic therapy for hepatocellular carcinoma: Chinese consensus-based interdisciplinary expert statements
Y Sun, W Zhang, X Bi, Z Yang, Y Tang, L Jiang, F Bi… - Liver Cancer, 2022 - karger.com
Background: Hepatocellular carcinoma (HCC) is the most common type of liver cancer and
causes many cancer-related deaths worldwide; in China, it is the second most prevalent …
causes many cancer-related deaths worldwide; in China, it is the second most prevalent …
[HTML][HTML] The management of post-transplantation recurrence of hepatocellular carcinoma
L Rajendran, T Ivanics, MPAW Claasen… - Clinical and …, 2022 - ncbi.nlm.nih.gov
The annual incidence of hepatocellular carcinoma (HCC) continues to rise. Over the last two
decades, liver transplantation (LT) has become the preferable treatment of HCC, when …
decades, liver transplantation (LT) has become the preferable treatment of HCC, when …
[HTML][HTML] Metabolic tumor volume predicts long-term survival after transplantation for unresectable colorectal liver metastases: 15 years of experience from the SECA …
H Grut, PD Line, T Syversveen, S Dueland - Annals of Nuclear Medicine, 2022 - Springer
Objective To report 15 years of experience with metabolic tumor volume (MTV) of liver
metastases from the preoperative 18F-FDG PET/CT to predict long-term survival after liver …
metastases from the preoperative 18F-FDG PET/CT to predict long-term survival after liver …
[HTML][HTML] The role of mTOR inhibitors after liver transplantation for hepatocellular carcinoma
L Todeschini, L Cristin, A Martinino, A Mattia, S Agnes… - Current …, 2023 - mdpi.com
Liver transplantation is a treatment option for nonresectable patients with early-stage HCC,
with more significant advantages when Milan criteria are fulfilled. An immunosuppressive …
with more significant advantages when Milan criteria are fulfilled. An immunosuppressive …
Impact of treatment modalities on patients with recurrent hepatocellular carcinoma after liver transplantation: preliminary experience
Z Yang, S Wang, XY Tian, QF Xie, L Zhuang… - … & Pancreatic Diseases …, 2020 - Elsevier
Background Post-liver transplantation (LT) hepatocellular carcinoma (HCC) recurrence still
occurs in approximately 20% of patients and drastically affects their survival. This study …
occurs in approximately 20% of patients and drastically affects their survival. This study …
[HTML][HTML] Epidemiology of liver cancer in Latin America: current and future trends
FJ Carrilho, DC Paranagua-Vezozzo… - Seminars in Liver …, 2020 - thieme-connect.com
Over 38,000 cases of hepatocellular carcinoma (HCC) are estimated to occur in Latin
America annually. The region is characterized by sociocultural heterogeneity and economic …
America annually. The region is characterized by sociocultural heterogeneity and economic …
[HTML][HTML] Long non-coding RNAs HERH-1 and HERH-4 facilitate cyclin A2 expression and accelerate cell cycle progression in advanced hepatocellular carcinoma
T Liu, Q Shi, L Yang, S Wang, H Song, Z Wang, X Xu… - BMC cancer, 2021 - Springer
Background The advanced hepatocellular carcinoma (HCC), such as the recurrent tumor
after liver transplantation (LT), is an obstacle of HCC treatment. The aim of this study was to …
after liver transplantation (LT), is an obstacle of HCC treatment. The aim of this study was to …
Recurrence of hepatocellular carcinoma after liver transplantation: Prognostic and predictive factors of survival in a Latin American cohort
C Maccali, AL Chagas, I Boin, E Quiñonez… - Liver …, 2021 - Wiley Online Library
Abstract Background & Aim Recurrence of hepatocellular carcinoma (HCC) after liver
transplantation (LT) has a poor prognosis, and the adjusted effect of different treatments on …
transplantation (LT) has a poor prognosis, and the adjusted effect of different treatments on …
[HTML][HTML] Main factors influencing long-term outcomes of liver transplantation in 2022
E Fuochi, L Anastasio, EN Lynch… - World Journal of …, 2023 - ncbi.nlm.nih.gov
Liver transplant (LT) outcomes have markedly improved in the recent decades, even if long-
term morbidity and mortality are still considerable. Most of late deaths are independent from …
term morbidity and mortality are still considerable. Most of late deaths are independent from …